Relation of Follicular Fluid Soluble Receptor for Advanced Glycation End-Products Concentration and Anti Mullerian Hormone in Polycystic Ovary Syndrome and Non-PCOS Women Referring to In Vitro Fertilization Center: Case-Control Study by Neda Emami, Ashraf Moini, Samira Vesali

“…This study investigated the relationship between soluble receptor for advanced glycationend-products (sRAGE) levels in follicular fluid (FF) and serum AMH levels in PCOS and non-PCOS women.Materials and Methods: Among 43 women of reproductive age who participated in this case-control study 26 non-PCOS women were assigned to the control group, while 17 participants were diagnosed with PCOS and allocatedto the case group. …”
Get full text

Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets by Xuedan Lai, Ling Wu, Peihong Lin, Lijiao You, Jianwen Ye

Subjects: “…Polycystic ovary syndrome (PCOS)…”
Get full text

Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers by Xiufen Zheng, Zikai Chen, Miao Liang, Liting Zhou, Miaoru Wang, Silin Zhang, Shuyun Zhang, Lei Ma, Wei Yi, Xiawen Liu

Subjects: “…PCOS…”
Get full text

A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS) by Nirmal Kumar, Neera Sharma, Smita Roy, Indu Chawla, Lokesh Kumar Sharma

“…Conclusion: In conclusion, novel androgen derivatives (11-KT and DHT) hold equivalent evidence for the evaluation of women with PCOS as they are raised in women with PCOS as compared to controls. …”
Get full text

Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome by Mina Amiri, Maryam Mousavi, Mahsa Noroozzadeh, Fereidoun Azizi, Fahimeh Ramezani Tehrani

Subjects: “…Polycystic ovary syndrome (PCOS)…”
Get full text

Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update by Imadeldin Elfaki, Rashid Mir, Mohamed E. Elnageeb, Abdullah Hamadi, Zeyad M. Alharbi, Ruqaiah I. Bedaiwi, Jamsheed Javid, Tariq Alrasheed, Dalal Alatawi, Basmah M. Alrohaf, Mohammed K. Abunab, Turki Ahmed Muqri

Subjects: “…polycystic ovarian syndrome (PCOS)…”
Get full text

Polycystic ovary syndrome in a patient with type B insulin resistance syndrome can improve with glucocorticoid treatment: a case report and literature review by Tetsuhiro Watanabe, Saori Okabe, Shohei Sakamoto

Subjects: “…polycystic ovary syndrome (pcos)…”
Get full text

Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study by Swati Dhar, Reena Yadav, Akash Tomar

“…Aims: This study aimed to investigate circulating serum zinc levels in PCOS subjects compared with non-PCOS subjects. Settings and Design: In this cohort study, PCOS subjects were compared with normal subjects aged between 18 and 35. …”
Get full text

miR-141-3p is Poorly Expressed in Polycystic Ovary Syndrome and Correlates with Glucose and Lipid Metabolism by Lingye Fan, Chunyan Wang, Ping Zhan, Yaofang Liu

“…Polycystic ovary syndrome (PCOS) is a common endocrinopathy with high prevalence. miR-141-3p downregulation was reported in PCOS rats. …”
Get full text

Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway by Chenye Wang, Caifei Ding, Zhoujia Hua, Chunyue Chen, Jia Yu

“…Pharmacology is a basic option for PCOS therapy; traditional Chinese medicine (TCM), as a significant part of complementary and alternative medicine, has a long history in the clinical management of PCOS. …”
Get full text

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome by Armaiti Parvez Mody, Maya Beth Lodish, Richard Joseph Auchus, Adina F. Turcu, Fei Jiang, Heather Gibson Huddleston

“…ABSTRACT Context Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS), yet the androgen(s) responsible remain ambiguous. …”
Get full text

Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study by R. A. Shreenidhi, Reeta Mahey, Monika Rajput, Rohitha Cheluvaraju, Ashish D. Upadhyay, Jai Bhagwan Sharma, Garima Kachhawa, Neerja Bhatla

“…The study also assessed these parameters amongst different PCOS phenotypes and determined their usefulness to define metabolically healthy PCOS (MH-PCOS) and metabolically unhealthy PCOS (MU-PCOS). …”
Get full text

Public Health System’s Preparedness to Address Polycystic Ovarian Syndrome: A Rapid Assessment Survey of Health-care Providers in India by Beena Nitin Joshi, Sharmeen Akhtar Shaikh, Amlin Shukla, Mohd. Ashraf Ganie, Imtiyaz Ahmad Wani, Vanita Suri, Neena Malhotra, Sarita Agarwal, Subhankar Chowdhury, Prasanta Kumar Bhattacharya, Rakesh Kumar Sahay, Roya Rozati, Puthiyaveettil Khadar Jabbar, Abilash Nair, Bharti Kulkarni, Aafia Rashid, Sunny Khajuria, Monica Rajput, Gaivee Vinam Meshram, Shouvik Chowdhury, Rahul Harish Bamon, Muhammed Shahid Pasha, Farhana Begum, Manoj Rema Aravind, Taruna Arora

“…Background: Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders largely affecting women of reproductive age group. …”
Get full text

Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome by Zahra Shaaban, Arezoo Khoradmehr, Amir Amiri-Yekta, Fariborz Nowzari, Mohammad Reza Jafarzadeh Shirazi, Amin Tamadon

“…Polycystic ovary syndrome (PCOS) is a common endocrinopathy in women. PCOS is characterized by anovulation, hyperandrogenism, polycystic ovaries, insulin resistance, and obesity. …”
Get full text

The Prevalence of Polycystic Ovary Syndrome in Women with Idiopathic Intracranial Hypertension by Inbal Avisar, Dan D. Gaton, Hirsch Dania, Hadas Stiebel-Kalish

“…The prevalence of PCOS in these women with IIH was compared with the reported prevalence of PCOS in the general population. …”
Get full text

The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort by Diane Schneider, Joel R. Gonzalez, Miya Yamamoto, Jingrong Yang, Joan C. Lo

“…This retrospective study utilized a source cohort of 1023 women with PCOS and 1023 women without PCOS who had a delivered pregnancy within Kaiser Permanente Northern California. …”
Get full text

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome by Susanne Tan, Nils Vollmar, Sven Benson, Jan-Peter Sowa, Lars P. Bechmann, Guido Gerken, Dagmar Fuhrer, Ali Canbay

“…Patients with initial IR were subdivided into dissolved (PCOS-exIR) and persistent IR (PCOS-PIR) after treatment and compared to an initially insulin sensitive PCOS group (PCOS-C). …”
Get full text

Impact of headache in women with polycystic ovary syndrome by Lina Zabulienë, V. Hendrixson, M. Urbonas, I. Ilias, D. Jatužis

“…Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine, metabolic, and androgen excess disorders among reproductive age women. …”
Get full text

A Study of Serum Adiponectin Levels in Patients with Polycystic Ovarian Syndrome and its Correlation with Various Cardiometabolic Risk Markers by G. Surendra Prasad, Uma Kaimal Saikia, Ashok Krishna Bhuyan, Abhamoni Baro

“…No difference in levels of adiponectin was found between the different PCOS phenotypes. Conclusion: Hypoadiponectinaemia was found to be associated with PCOS irrespective of obesity in PCOS subjects. …”
Get full text

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome by Carlos Moran, Monica Arriaga, Gustavo Rodriguez, Segundo Moran

“…The insulin resistance is present in the majority of patients with obesity and/or PCOS and it is more frequent and of greater magnitude in obese than in non obese PCOS patients. …”
Get full text